Autoantibody-catalyzed hydrolysis of amyloid beta peptide
- PMID: 18086674
- DOI: 10.1074/jbc.M707983200
Autoantibody-catalyzed hydrolysis of amyloid beta peptide
Abstract
We describe IgM class human autoantibodies that hydrolyze amyloid beta peptide 1-40 (Abeta40). A monoclonal IgM from a patient with Waldenström's macroglobulinemia hydrolyzed Abeta40 at the Lys-28-Gly-29 bond and Lys-16-Ala-17 bonds. The catalytic activity was inhibited stoichiometrically by an electrophilic serine protease inhibitor. Treatment with the catalytic IgM blocked the aggregation and toxicity of Abeta40 in neuronal cell cultures. IgMs purified from the sera of patients with Alzheimer disease (AD) hydrolyzed Abeta40 at rates superior to IgMs from age-matched humans without dementia. IgMs from non-elderly humans expressed the least catalytic activity. The reaction rate was sufficient to afford appreciable degradation at physiological Abeta and IgM concentrations found in peripheral circulation. Increased Abeta concentrations in the AD brain are thought to induce neurodegenerative effects. Peripheral administration of Abeta binding antibodies has been suggested as a potential treatment of AD. Our results suggest that catalytic IgM autoantibodies can help clear Abeta, and they open the possibility of using catalytic Abs for AD immunotherapy.
Similar articles
-
Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.PLoS One. 2010 Nov 10;5(11):e13928. doi: 10.1371/journal.pone.0013928. PLoS One. 2010. PMID: 21085663 Free PMC article.
-
Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease.Autoimmun Rev. 2008 May;7(5):391-7. doi: 10.1016/j.autrev.2008.03.004. Epub 2008 Apr 9. Autoimmun Rev. 2008. PMID: 18486927 Free PMC article. Review.
-
Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S43-9. doi: 10.1007/s10875-010-9414-5. J Clin Immunol. 2010. PMID: 20454852 Free PMC article. Review.
-
Beneficial catalytic immunity to abeta peptide.Rejuvenation Res. 2010 Apr-Jun;13(2-3):179-87. doi: 10.1089/rej.2009.0958. Rejuvenation Res. 2010. PMID: 20370602 Free PMC article. Review.
-
Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.Neurobiol Aging. 2011 Aug;32(8):1379-87. doi: 10.1016/j.neurobiolaging.2009.08.011. Epub 2009 Sep 24. Neurobiol Aging. 2011. PMID: 19781815
Cited by
-
Physiological IgM class catalytic antibodies selective for transthyretin amyloid.J Biol Chem. 2014 May 9;289(19):13243-58. doi: 10.1074/jbc.M114.557231. Epub 2014 Mar 19. J Biol Chem. 2014. PMID: 24648510 Free PMC article. Clinical Trial.
-
Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.PLoS One. 2010 Nov 10;5(11):e13928. doi: 10.1371/journal.pone.0013928. PLoS One. 2010. PMID: 21085663 Free PMC article.
-
Autoantibodies with enzymatic properties in human autoimmune diseases.J Autoimmun. 2011 Sep;37(2):144-50. doi: 10.1016/j.jaut.2011.05.007. Epub 2011 May 31. J Autoimmun. 2011. PMID: 21624820 Free PMC article. Review.
-
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders.Int J Mol Sci. 2024 Jun 18;25(12):6683. doi: 10.3390/ijms25126683. Int J Mol Sci. 2024. PMID: 38928395 Free PMC article. Review.
-
Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.Int J Mol Sci. 2020 Jul 29;21(15):5392. doi: 10.3390/ijms21155392. Int J Mol Sci. 2020. PMID: 32751323 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
